"The St. Mark's Hospital Emergency Room provides 24/7 emergency care to patients in Millcreek, Salt Lake City and it's surrounding communities. With a Level II Trauma Center, St. Mark's is here for any emergency, both large or small. You can expect short ER wait times and compassionate care from our specially trained emergency staff. Check current ER wait times on our website."

During the past decade, St. Mark's Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 9 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mark's Hospital" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Sirtex Medical" with 2 trials sponsored and "AlloCure Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mark's Hospital" #1 collaborator was "Biocompatibles UK Ltd" with 2 trials as a collaborator, "DFINE Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Intermountain Health Care, Inc." with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "St. Mark's Hospital" are "Colorectal Cancer Metastatic" (2 trials), "Respiratory Tract Infection" (2 trials), "Acute Kidney Injury" (1 trials), "Aortic Valve Disorder" (1 trials) and "Aortic Valve Insufficiency" (1 trials). Many other conditions were trialed in "St. Mark's Hospital" in a lesser frequency.

Most popular intervention types in "St. Mark's Hospital" are "Device" (11 trials), "Drug" (5 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "TheraSphere" (2 trials), "AMPLATZER PFO Occluder" (1 trials), "Administration of MSC" (1 trials) and "Anti-digoxin antibody (FAB fragment)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Mark's Hospital" are 14 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "St. Mark's Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in St. Mark's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mark's Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".